tiprankstipranks

MARK A GOLDSMITH Insider Profile

11 Followers
MARK A GOLDSMITH, President & CEO, Director at Revolution Medicines, holds 922.81K shares in Revolution Medicines (Ticker: RVMD), holds 89.86K shares in Constellation Pharmaceuticals (Ticker: CNST).
tipranks
MARK A GOLDSMITH

MARK A GOLDSMITH
Revolution Medicines (RVMD)
President & CEO, Director

Ranked #100,843 out of 108,921 Corporate Insiders

Profitable Transactions

43%
3 out of 7 Profitable Transactions

Average Return

-40.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$192M
100.00%
A breakdown of MARK A GOLDSMITH's holdings

Insider Roles

Revolution Medicines
(RVMD)
President & CEO, Director
Roles that MARK A GOLDSMITH holds in companies

Most Profitable Insider Trade

Stock:
Revolution Medicines
(RVMD)
Rating:Informative Sell
Date:Sep 21, 2021 - Sep 21, 2022
Return:+45.50%
The most profitable trade made by MARK A GOLDSMITH

MARK A GOLDSMITH's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Revolution Medicines
Aug 25, 2026
President & CEO, Director
Uninformative Buy
378.40K
$191.65M
CNST
Constellation Pharmaceuticals
Dec 28, 2020
Uninformative Sell
140.74K
$3.05M
List of latest transactions for each holding click on a transaction to see MARK A GOLDSMITH's performance on stock

MARK A GOLDSMITH insider profile FAQ

What is the percentage of profitable transactions made by MARK A GOLDSMITH?
The percentage of profitable transactions made by MARK A GOLDSMITH is 43%.
    What is the average return per transaction made by MARK A GOLDSMITH?
    The average return per transaction made by MARK A GOLDSMITH is -40.20%.
      What stocks does MARK A GOLDSMITH hold?
      MARK A GOLDSMITH holds: RVMD, CNST stocks.
        What was MARK A GOLDSMITH’s latest transaction?
        MARK A GOLDSMITH latest transaction was an Uninformative Buy of $378.40K.
          What was MARK A GOLDSMITH's most profitable transaction?
          MARK A GOLDSMITH’s most profitable transaction was an Informative Sell of RVMD stock on September 21, 2021. The return on the trade was 45.50%.
            What is MARK A GOLDSMITH's role in Revolution Medicines?
            MARK A GOLDSMITH's role in Revolution Medicines is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.